Stock Scorecard
Stock Summary for Steris Plc (STE) - $205.04 as of 5/2/2024 12:34:53 PM EST
Total Score
12 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for STE
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for STE
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for STE
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for STE
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for STE
Financial Details for STE
Company Overview |
|
|---|---|
| Ticker | STE |
| Company Name | Steris Plc |
| Country | USA |
| Description | Steris Corporation is an American Irish-domiciled medical equipment company specializing in sterilization and surgical products for the US healthcare system. |
| Sector Name | LIFE SCIENCES |
| Industry Name | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Most Recent Quarter | 12/31/2023 |
| Next Earnings Date | 5/9/2024 |
Stock Price History |
|
| Last Day Price | 205.04 |
| Last Day Price Updated | 5/2/2024 12:34:53 PM EST |
| Last Day Volume | 358,970 |
| Average Daily Volume | 539,743 |
| 52-Week High | 252.19 |
| 52-Week Low | 183.48 |
| Last Price to 52 Week Low | 11.75% |
Valuation Measures |
|
| Trailing PE | 35.97 |
| Industry PE | 59.21 |
| Sector PE | 53.36 |
| 5-Year Average PE | 28.63 |
| Free Cash Flow Ratio | 99.53 |
| Industry Free Cash Flow Ratio | 37.64 |
| Sector Free Cash Flow Ratio | 30.86 |
| Current Ratio Most Recent Quarter | 2.43 |
| Total Cash Per Share | 2.06 |
| Book Value Per Share Most Recent Quarter | 64.93 |
| Price to Book Ratio | 3.14 |
| Industry Price to Book Ratio | 6.35 |
| Sector Price to Book Ratio | 22.00 |
| Price to Sales Ratio Twelve Trailing Months | 3.73 |
| Industry Price to Sales Ratio Twelve Trailing Months | 7.00 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.14 |
Share Statistics |
|
| Total Shares Outstanding | 98,814,000 |
| Market Capitalization | 20,260,822,560 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 2/22/2024 |
| Last Dividend Amount | 0.52 |
| Current Dividend Amount | 0.52 |
| Dividend Aristocrat? | False |
| Trailing Annual Dividend Rate | 2.03 |
| Trailing Annual Dividend Yield | 0.99% |
| Forward Annual Dividend Rate | 2.21 |
| Forward Annual Dividend Yield | 1.08% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 0.85% |
| 5-Year Average Dividend Yield | 0.86% |
| 1-Year Dividend Growth Rate Percentage | 10.00% |
| 3-Year Dividend Growth Rate Percentage | 9.21% |
| 5-Year Dividend Growth Rate Percentage | 8.67% |
| All-Time Dividend Growth Rate Percentage | 16.85% |
| Dividend Payout Ratio | 35.68% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 14.50% |
| Annual Earnings Growth | -56.12% |
| Reported EPS 12 Trailing Months | 5.70 |
| Reported EPS Past Year | 6.25 |
| Reported EPS Prior Year | 8.21 |
| Net Income Twelve Trailing Months | 566,841,000 |
| Net Income Past Year | 107,030,000 |
| Net Income Prior Year | 243,888,000 |
| Quarterly Revenue Growth YOY | 14.80% |
| 5-Year Revenue Growth | 15.54% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 203,684,000 |
| Total Cash Past Year | 7,069,000 |
| Total Cash Prior Year | 8,520,000 |
| Net Cash Position Most Recent Quarter | -3,027,391,000 |
| Net Cash Position Past Year | -3,011,586,000 |
| Long Term Debt Past Year | 3,018,655,000 |
| Long Term Debt Prior Year | 2,945,481,000 |
| Total Debt Most Recent Quarter | 3,231,075,000 |
| Equity to Debt Ratio Past Year | 0.67 |
| Equity to Debt Ratio Most Recent Quarter | 0.67 |
| Total Stockholder Equity Past Year | 6,077,198,000 |
| Total Stockholder Equity Prior Year | 6,532,356,000 |
| Total Stockholder Equity Most Recent Quarter | 6,415,396,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -6.22 |
| MACD Signal | -6.14 |
| 20-Day Bollinger Lower Band | 199.80 |
| 20-Day Bollinger Middle Band | 220.33 |
| 20-Day Bollinger Upper Band | 240.87 |
| Beta | 0.79 |
| RSI | 34.58 |
| 50-Day SMA | 217.56 |
| 200-Day SMA | 201.12 |
System |
|
| Modified | 5/2/2024 12:11:21 PM EST |